Cas No.: 136461-80-8
PRODUCT INFORMATION
Description
Osteocalcin (1-49) (human) is a vitamin K-dependent, non-collagenous bone matrix protein synthesized by osteoblasts. It undergoes post-translational γ-carboxylation, enabling high calcium affinity to regulate skeletal mineralization. This bone-specific hormone also exhibits chemotactic activity, facilitating the recruitment of osteoclast precursors and other cellular components critical for maintaining bone remodeling homeostasis. It is a key biomarker for bone formation studies.
Molecular Weight
5929.44
Purity
> 95%
Formula
C₂₆₉H₃₈₁N₆₇O₈₂S₂
Product Type
Targeting Peptide
Sequence
Tyr-Leu-Tyr-Gln-Trp-Leu-Gly-Ala-Pro-Val-Pro-Tyr-Pro-Asp-Pro-Leu-Gla-Pro-Arg-Arg-Gla-Val-Cys-Gla-Leu-Asn-Pro-Asp-Cys-Asp-Glu-Leu-Ala-Asp-His-Ile-Gly-Phe-Gln-Glu-Ala-Tyr-Arg-Arg-Phe-Tyr-Gly-Pro-Val (Disulfide bridge: Cys23-Cys29)
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- Tumor Targeted Pro-apoptotic Peptide (CAT#: OLY-1025-YS-48)
- CGGRGD Targeting Peptide (CAT#: OLY-1025-YS-26)
- mUNO Targeting Peptide (CAT#: OLY-1025-YS-29)
- CXCL9(74-103) Targeting Peptide (CAT#: OLY-1025-YS-42)
- CK3 Targeting Peptide (CAT#: OLY-1025-YS-22)
- M2 Targeting Peptide (CAT#: OLY-1025-YS-40)
- Breast Cancer Targeting Peptide 18-4 (CAT#: OLY-1025-YS-23)
- C16Y Targeting Peptide (CAT#: OLY-1025-YS-7)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
